George Kelly Martin's most recent trade in TriSalus Life Sciences Inc was a trade of 9 Common Stock done at an average price of $5.6 . Disclosure was reported to the exchange on Aug. 28, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TriSalus Life Sciences Inc | George Kelly Martin | Director | Sale of securities on an exchange or to another person at price $ 5.56 per share. | 28 Aug 2024 | 9 | 247,176 | - | 5.6 | 50 | Common Stock |
TriSalus Life Sciences Inc | George Kelly Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
TriSalus Life Sciences Inc | George Kelly Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy) |